Collectively, our studies revealed a tumor suppressor gene, WSX1, which functions as a “guardian” of CD8+ T cell-mediated cancer immunosurveillance and acts as a homeostatic “supervisor” of the immune checkpoint PD-L1. The gene discussed is CD274; the disease is cancer.